FDA - MAI 2015 - Nanotechnology Fact Sheet. Contents Nanotechnology Overview Nanotechnology is an emerging technology that has the potential for use in a broad array of FDA-regulated products, including medical products, foods and cosmetics.
Nanomaterials, developed using nanotechnology, are measured in nanometers — equal to about one-billionth of a meter — so small that they cannot be seen with a regular microscope. These nanomaterials can have different chemical, physical, or biological properties than their conventionally-scaled counterpart materials used in many products regulated by FDA. FDA has long encountered the combination of promise, risk, and uncertainty that accompanies emerging technologies.
Strong science is critical to FDA’s ongoing review of the products it regulates. FDA is maintaining a product-focused and science-based regulatory policy to appropriately regulate products using this emerging technology. FDA’s Action on Nanotechnology The four final guidances are: For More Information. USDA 27/04/15 USDA Awards $3.8 Million in Grants for Nanotechnology Research. Printer-friendly version PDF version WASHINGTON, April 27, 2015 – The U.S.
Department of Agriculture's (USDA) National Institute of Food and Agriculture (NIFA) today announced more than $3.8 million in funding to support grants focused on using nanotechnology to find solutions to societal challenges such as food security, nutrition, food safety, and environmental protection. The awards were made through NIFA's Agriculture and Food Research Initiative (AFRI), which is authorized by the 2014 Farm Bill.
"Nanoscale science, engineering, and technology embrace opportunities in a broad range of critical challenges facing agriculture and food systems" said NIFA director, Sonny Ramaswamy. Past projects include a Cornell University and Rensselaer Polytechnic Institute venture that led to the development of a new nanotechnology that could keep bacteria from sticking to medical equipment and food processing machinery. Fiscal year 2014 projects include: OCDE AOUT 2007 Current Developments in Manufactured Nanomaterials in the United States. RSC 30/06/10 EPA's oversight of nanomaterials questioned. EPA 09/11/06 Nanotechnology - Pesticide Program Dialogue Pesticide Program Dialogue Committee. EPA MAI 2007 EPA AND NANOTECHNOLOGY: OVERSIGHT for THE 21st CENTURY.
FDA - page Nanotechnology FDA Nanotechnology Task Force Report - July 2007. National Nanotechnology Initiative. NANONORMA 05/05/10 USA – L’implication renforcée de la FDA en matière de recherche sur la sécurité des nanomatériaux? Présentation devant le sénat américain d’un projet de loi visant au développement d’un programme de recherche sur la sécurité des nanomatériaux au sein de la Food and Drug Administration Les sénateurs américains M.
Pryor et B. Cardin ont proposé en janvier 2010 d'amender le "Federal Food, Drug, and Cosmetic Act" pour y introduire un programme sur les nanotechnologies. Le projet de loi, qui est dénommé "Nanotechnology Safety Act of 2010", prévoit le développement à l'intérieur de la FDA d'un programme scientifique visant à évaluer le potentiel toxicologique des nanomatériaux et leurs effets sur le système biologique. Parmi les actions spécifiques évoquées figurent notamment l'analyse des données scientifiques disponibles, la création de bases de données organisant les informations collectées et la promotion de la coopération avec les différentes agences participant au "National Nanotechnology Initiative".
GAO 25/05/10 Nanotechnology: Nanomaterials Are Widely Used in Commerce, but EPA Faces Challenges in Regulating Risk. Nanotechnology involves the ability to control matter at the scale of a nanometer--one billionth of a meter.
The world market for products that contain nanomaterials is expected to reach $2.6 trillion by 2015. In this context, GAO (1) identified examples of current and potential uses of nanomaterials, (2) determined what is known about the potential human health and environmental risks from nanomaterials, (3) assessed actions EPA has taken to better understand and regulate the risks posed by nanomaterials as well as its authorities to do so, and (4) identified approaches that other selected national authorities and actions U.S. states have taken to address the potential risks associated with nanomaterials.
GAO analyzed selected laws and regulations, reviewed information on EPA's Nanoscale Materials Stewardship Program, and consulted with EPA officials and legal experts to obtain their perspectives on EPA's authorities to regulate nanomaterials. Status Legend: Status: Open.